Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...

The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...

Data from the phase 1/2 RMC-6236-001 trial show that the RAS(ON) multiselective inhibitor daraxonrasib yielded responses in pretreated RAS-mutated PDAC. In the phase 1/2 trial, daraxonrasib ...

Kestrel today announced that the first patient has been dosed in its phase 1 trial of KST-6051, an oral small molecule meant to inhibit multiple different kinds of KRAS mutations. (iStock / Getty ...

Add the following CSS to the header block of your HTML document. Then add the mark-up below to the body block of the same document. .videoWrapper { position: relative; padding-bottom: 56.25%; ...

Roopesh is a seasoned freelance writer with over six years of experience spanning automotive, technology, and consumer electronics. His work has appeared on leading platforms such as MakeUseOf, How-to ...

The inline-six is enjoying a massive second act, and it's time we started paying attention. After all, inline-6 engines are much smoother than V6 and inline-4 engines and are even more balanced than ...

A little over a year ago, the U.S. Army Corps of Engineers’ Hydrologic Engineering Center (HEC) quietly launched new software that provides a whole new way of visualizing river analysis. This new ...

NewGenIVF Group Limited (NASDAQ: NIVF) announced its intention to exercise an option to convert its Ras Al Khaimah development project from a joint venture structure to a joint development structure ...

Michal studies Automotive Journalism at Coventry University in the UK, and has been writing for CarBuzz since March 2025. He was nominated for student culture piece of the year recently and has been ...